2000 Participants Needed

Observational Study for Primary Sclerosing Cholangitis

(WIND-PSC Trial)

Recruiting at 12 trial locations
MS
JN
SR
PK
Overseen ByPriya Kannusamy
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Arbor Research Collaborative for Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to gather real-world data from adults with primary sclerosing cholangitis (PSC), a liver disease affecting bile ducts. The collected information will help design and support future clinical trials for PSC treatments. Eligible participants are adults with confirmed large duct PSC and should not have other significant liver diseases, such as hepatitis or alcoholic hepatitis. Those with PSC who experience frequent symptoms or complications might be a good fit for this study. As an unphased trial, this study offers a valuable opportunity to contribute to the foundational understanding of PSC and influence future treatment strategies.

Why are researchers excited about this trial?

Unlike the standard of care for primary sclerosing cholangitis (PSC), which often involves managing symptoms with medications like ursodeoxycholic acid or endoscopic procedures, this trial is focused on understanding the disease progression across a global cohort without testing a specific new treatment. Researchers are excited about this trial because it provides a comprehensive, real-world view of how PSC affects patients worldwide. By gathering data on diverse patient experiences and outcomes, the study aims to uncover insights that could lead to better-targeted future treatments and improve overall patient care standards for PSC.

Who Is on the Research Team?

CL

Cynthia Levy, MD

Principal Investigator

University of Miami

SR

Stephen Rossi, PharmD

Principal Investigator

PSC Partners Seeking a Cure

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 18 and 75 years old and can follow study instructions.
I have been diagnosed with large duct primary sclerosing cholangitis.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Enrollment

Collection of baseline clinical and biomarker data at enrollment

1 visit
1 visit (in-person)

Observational Follow-up

Quarterly and annual visits for collection of liver-related clinical outcomes, safety events, biomarkers, imaging assessments, and patient-reported outcomes

5 years
Quarterly and annual visits (in-person)

What Are the Treatments Tested in This Trial?

Find a Clinic Near You

Who Is Running the Clinical Trial?

Arbor Research Collaborative for Health

Lead Sponsor

Trials
21
Recruited
35,500+

PSC Partners Seeking a Cure

Lead Sponsor

Trials
2
Recruited
2,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security